Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.610
+0.070 (2.76%)
At close: Apr 2, 2025, 4:00 PM
2.576
-0.034 (-1.30%)
After-hours: Apr 2, 2025, 6:00 PM EDT

Cyclerion Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-3.06-5.26-44.08-51.65-77.8
Upgrade
Depreciation & Amortization
--0.070.472.3
Upgrade
Loss (Gain) From Sale of Assets
---6.320.16
Upgrade
Asset Writedown & Restructuring Costs
-3.3---
Upgrade
Stock-Based Compensation
0.631.076.259.6114.99
Upgrade
Other Operating Activities
-0.36---2.68-4.54
Upgrade
Change in Accounts Receivable
-0.560.100.031.35
Upgrade
Change in Accounts Payable
-0.45-1.771.140.39-1.1
Upgrade
Change in Other Net Operating Assets
-0.54-2.93-40.99-7.84
Upgrade
Operating Cash Flow
-4.33-21.25-40.61-36.52-72.49
Upgrade
Capital Expenditures
----0.01-1.52
Upgrade
Sale of Property, Plant & Equipment
---1.461.54
Upgrade
Other Investing Activities
-10.4---
Upgrade
Investing Cash Flow
-10.4-1.460.02
Upgrade
Short-Term Debt Issued
----3.51
Upgrade
Total Debt Issued
----3.51
Upgrade
Net Debt Issued (Repaid)
----3.51
Upgrade
Issuance of Common Stock
-1.980.0330.7924.58
Upgrade
Financing Cash Flow
-5.020.0330.7928.09
Upgrade
Foreign Exchange Rate Adjustments
-0.010.0100-0.01
Upgrade
Net Cash Flow
-4.34-5.81-40.58-4.27-44.39
Upgrade
Free Cash Flow
-4.33-21.25-40.61-36.52-74.01
Upgrade
Free Cash Flow Margin
-216.65%--13673.74%-926.53%-3223.61%
Upgrade
Free Cash Flow Per Share
-1.72-9.09-18.69-18.66-48.69
Upgrade
Levered Free Cash Flow
-3.54-9.52-8.67-20.34-38.55
Upgrade
Unlevered Free Cash Flow
-3.54-9.52-8.67-20.33-38.55
Upgrade
Change in Net Working Capital
1.94.563.4-3.552.48
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q